UAlbany Chemist Available to Discuss Eli Lilly Alzheimer’s Drug

ALBANY, N.Y. (July 9, 2024) — Last week, the Food and Drug Administration (FDA) approved a new Alzheimer’s medication developed by Eli Lilly that has shown in clinical trials to moderately delay the progression of memory and cognitive decline in…

Project to improve health equity in Indianapolis expands with funding from Lilly

Indiana University has received a five-year, $5 million grant from Eli Lilly and Co. to expand the Diabetes Impact Project, which aims to improve health equity in three Indianapolis neighborhoods where residents are predominantly people of color.